We serve Chemical Name:2-Carbomethoxyethyldimethoxymethylsilane CAS:76301-03-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Carbomethoxyethyldimethoxymethylsilane
CAS.NO:76301-03-6
Synonyms:2-Carbomethoxyethyldimethoxymethylsilane
Molecular Formula:C7H16O4Si
Molecular Weight:192.28500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:212.977ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:44.76000
Exact Mass:192.08200
LogP:0.91430
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Carbomethoxyethyldimethoxymethylsilane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Carbomethoxyethyldimethoxymethylsilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Carbomethoxyethyldimethoxymethylsilane Use and application,2-Carbomethoxyethyldimethoxymethylsilane technical grade,usp/ep/jp grade.
Related News: Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. 2-Carbomethoxyethyldimethoxymethylsilane manufacturer Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. 2-Carbomethoxyethyldimethoxymethylsilane supplier Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. 2-Carbomethoxyethyldimethoxymethylsilane vendor Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. 2-Carbomethoxyethyldimethoxymethylsilane factory What’s the background?
